Omega-3 fatty acids produce endocannabinoid-like compounds that preferentially activate anti-inflammatory CB2 receptors

Researchers developed novel quantification assays to measure multiple NAEs in biological tissues and their rates of hydrolysis by fatty acid amide hydrolase (FAAH). The full range of NAEs was tested in rapid-response assays at CB1, CB2, and TRPV1 receptors to determine receptor selectivity profiles.

This study provides a molecular bridge between two major areas of health research: omega-3 fatty acids and the endocannabinoid system. If omega-3 derived endocannabinoids preferentially activate anti-inflammatory CB2 receptors, it could explain why diets high in omega-3 fatty acids are associated with reduced inflammation and why the omega-6 to omega-3 ratio in the diet matters for health.

The connection between dietary fats and the endocannabinoid system could reshape how we think about both nutrition and cannabinoid medicine. If the ratio of omega-6 to omega-3 in the diet shifts the balance of endocannabinoid signaling toward CB1 versus CB2 activation, dietary interventions could potentially modulate endocannabinoid tone and inflammation.

Receptor activation was tested in cell-based assays, and the in vivo significance of the CB2 selectivity of omega-3 NAEs remains to be confirmed. The study did not directly test whether dietary omega-3 supplementation changes the NAE profile in tissues enough to produce measurable anti-inflammatory effects. Concentrations effective in assays may not reflect physiological levels.